+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The prognostic significance of deletion of the long arm of chromosome 20 in myeloid disorders



The prognostic significance of deletion of the long arm of chromosome 20 in myeloid disorders



Leukemia 8(1): 67-71



A review of patients with myeloid disorders presenting to a large cytogenetic referral centre over a ten year period was undertaken to assess the clinical relevance of the presence of del(20q) in their malignant karyotypes. Twenty-six patients were identified, four with myeloproliferative disorders (MPD), 15 with myelodysplastic syndromes (MDS) and seven with acute leukemia. The presence of del(20q) in four patients with MPD did not appear to adversely affect survival, with ill patients alive 18 to 184 months post diagnosis. However, the 15 patients with MDS had a median survival of only 12 months. Seven of these patients developed acute leukemia including three of four patients with refractory anemia with ringed sideroblasts (RARS). Of the seven patients with acute leukemia de novo and del(20q), six were treated with only two achieving complete remission. The median duration of survival for these seven patients was 5 months. These results, when compared with published survival data from the MIC Cooperative Group, indicated that del(20q) in MDS is associated with a high rate of transformation to acute leukemia and a poor prognosis. In de novo acute leukemia, del(20q) is associated with a poor response to treatment and reduced survival.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 009611167

Download citation: RISBibTeXText

PMID: 8289501


Related references

The prognostic significance of the partial deletion of the long arm of chromosome 20 in myelodysplastic syndromes and other myeloid disorders. Leukemia Research 23(SUPPL 1): S10, 1999

Deletion of the long arm of chromosome 20 [del(20)(q11)] in myeloid disorders. Blood 52(5): 868-877, 1978

Evidence for two molecular steps in the pathogenesis of myeloid disorders associated with deletion of chromosome 7 long arm. Leukemia 11(12): 2097-2104, 1998

Evidence for two molecular steps in the pathogenesis of myeloid disorders associated with deletion of chromosome 7 long arm. Leukemia (basingstoke). 11(12): 2097-2104,., 1997

Chromosome 7 long arm deletion in myeloid disorders: a narrow breakpoint region in 7q22 defined by molecular mapping. Blood 73(1): 230-234, 1989

Assignment of CSF-1 to 5q33.1: evidence for clustering of genes regulating hematopoiesis and for their involvement in the deletion of the long arm of chromosome 5 in myeloid disorders. Proceedings of the National Academy of Sciences of the United States of America 84(9): 2970-2974, 1987

Prognostic significance of deletion of the long arm of chromosome 20 in patients with myelodysplastic syndrome (MDS): a study of the Greek MDS Study Group. European Journal of Haematology 78(1): 89-90, 2007

Prognostic significance of deletion of the long arm of chromosome 20 in patients with myelodysplastic syndrome (MDS): a study of the Greek MDS Study Group. European Journal of Haematology 0(0): 060928002456003-???, 2006

Deletion of chromosome arm 15q and hitherto unreported duplication of del(15q) in myeloid disorders. Cancer Genetics and Cytogenetics 151(2): 146-151, 2004

Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: Prognostic implications. Lancet (North American Edition) 343(8912): 1531-1534, 1994

Deletion of derivative chromosome 9 has no prognostic impact on patients with chronic myeloid leukemia treated with imatinib mesylate. Blood 102(11): 184a, November 16, 2003

Deletion of the multidrug resistance-associated protein gene in acute myeloid leukemia with inversion of chromosome 16 has no prognostic impact. Leukemia 14(6): 1154, 2000

Prognostic-significance of chromosome 5q and 17p allelic deletion in colorectal adenocarcinomas. International Journal of Oncology 7(3): 631-635, 1995

Deletion of the long arm but not the 5q31 region of chromosome 5 in myeloid malignancies. Leukemia Research 36(3): E43-E45, 2012

Methods of detection and prognostic significance of genetic material increase of the short arm of chromosome 2 and a deletion of the short arm of chromosome 1 in patients with neuroblastoma. Voprosy Onkologii 59(5): 591-598, 2013